Florence Wu

4PUBLICATIONS

21CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|May 13, 2026

mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversion.

|Aug 23, 2024

Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient.

Florence T H Wu, James T Topham, Chris J O'Callaghan

|Mar 26, 2024

Treating anaplastic lymphoma kinase (ALK) fusion-driven metastatic non-small cell lung cancer (NSCLC) with alectinib through pregnancy.

Florence Wu, Rebekah Rittberg, Kenneth Lim

|Jun 14, 2021

Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer.

Kabir A Khan, Florence Th Wu, William Cruz-Munoz

Pageof 1

Frequent Collaborators

Harriet Feilotter

Hagen F Kennecke

Dongsheng Tu

Eric X Chen

Jonathan M Loree

William W Feng

Alexander W Ying

Daren C Card

Nikolina Radulovich

Katrina Hueniken

Frequent Collaborators

Harriet Feilotter

Hagen F Kennecke

Dongsheng Tu

Eric X Chen